Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is seven-membered consisting of one nitrogen and six carbons > Polycyclo ring system having the seven-membered hetero ring as one of the cyclos > Patents

Resources

Home

Browse by:

Browse by Category: Main > Health & Medicine

Class Information
Number: 514/213.01
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is seven-membered consisting of one nitrogen and six carbons > Polycyclo ring system having the seven-membered hetero ring as one of the cyclos
Description: Subject matter wherein the seven-membered hetero ring is one of the cyclos of a polycyclo ring.

Sub-classes under this class:

Class Number	Class Name	Patents
514/217.01	3-benzazepines (including hydrogenated)	116
514/215	Additional hetero atom in the polycyclo ring system	383
514/214.01	Ring nitrogen of the seven-membered hetero ring is shared by an additional cyclo of the polycyclo ring system	123
514/217	Tricyclo ring system having the seven-membered hetero ring a one of the cyclos	331
514/216	Two of the cyclos share at least three ring carbons (i.e., bridged)	91

Patents under this class:

1 2 3 4

Patent Number	Title Of Patent	Date Issued
7074781	Condensed azepines as vasopressin agonists	Jul. 11, 2006
7067510	Dihydro-dibenzo[b,e]oxepine based selective estrogren receptor modulators, compositions and methods	Jun. 27, 2006
7008938	Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient	Mar. 7, 2006
6995154	Heterocyclic topoisomerase poisons	Feb. 7, 2006
6953791	Dipeptide derivatives	Oct. 11, 2005
6936602	Benzazepine derivatives, process for the preparation of the same and uses thereof	Aug. 30, 2005
6927238	Regulation of phospholipase D activity	Aug. 9, 2005
6864288	Regulation of phospholipase D activity	Mar. 8, 2005
6855707	Method for the treatment of lipid and glucose metabolism disorders	Feb. 15, 2005
6815440	Cyclic and heterocyclic N-substituted .alpha.-iminohydroxamic and -carboxylic acids	Nov. 9, 2004
6809092	Benezene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient	Oct. 26, 2004
6762178	Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors	Jul. 13, 2004
6686351	Compounds and methods for modulation of estrogen receptors	Feb. 3, 2004
6667302	Heterocyclic topoisomerase poisons	Dec. 23, 2003
6638925	Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments	Oct. 28, 2003
6630463	Heterocycle-containing carboxylic acid derivative and drug containing the same	Oct. 7, 2003
6627636	HMG-CoA reductase inhibitors and method	Sep. 30, 2003
6602864	Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds	Aug. 5, 2003
6593322	Compounds and methods for modulation of estrogen receptors	Jul. 15, 2003
6562828	Amidine compounds	May. 13, 2003
6534496	Thermogenic composition and benzazepine thermogenics	Mar. 18, 2003
6525043	Use of ion channel modulating agents	Feb. 25, 2003
6514964	Fused cycloheptane and fused azacycloheptane compounds and their methods of use	Feb. 4, 2003
6495542	Benzamide derivatives as vasopressin antagonists	Dec. 17, 2002
6468971	Maintaining kidney function during surgery or trauma	Oct. 22, 2002
6436923	Compounds and methods for modulation of estrogen receptors	Aug. 20, 2002
6413955	Integrin receptor antagonists	Jul. 2, 2002
6380184	Benzoazepines and analogs thereof useful as growth hormone secretagogues	Apr. 30, 2002
6350760	Substituted piperidines as melanocortin-4 receptor agonists	Feb. 26, 2002
6346527	Guanidine derivatives	Feb. 12, 2002
6340678	4,4-difluoro-2,3,4,5-tetrahydro-1H-1-benzoazepine derivatives and drug compositions containing them	Jan. 22, 2002
6335327	Benzoheterocyclic derivatives	Jan. 1, 2002
6319918	Substituted indolinones with kinase inhibitory activity	Nov. 20, 2001
6281227	Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds	Aug. 28, 2001
6268359	Preventives or remedies for vision disorders	Jul. 31, 2001
6262049	Method of reducing nicotine and tobacco craving in mammals	Jul. 17, 2001
6262050	Topical composition containing capsazepine	Jul. 17, 2001
6194403	Tacrine derivatives for treating Alzheimer's disease	Feb. 27, 2001
6191126	Topical use of .kappa. opioid agonists to treat ocular pain	Feb. 20, 2001
6191144	Method of using angiotensin converting enzyme inhibitor to stimulate angiogenesis	Feb. 20, 2001
6174878	Topical use of kappa opioid agonists to treat otic pain	Jan. 16, 2001
6172061	Pharmaceutical composition for antagonizing CCR5 comprising anilide derivative	Jan. 9, 2001
6166006	Anilide derivative, production and use thereof	Dec. 26, 2000
6140317	Pyrrolopyrimidines and processes for their preparation	Oct. 31, 2000
6124277	Antithrombotic agents	Sep. 26, 2000
6117898	Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase	Sep. 12, 2000
6110934	Substituted benzamide derivatives and their use as anticonvulsants	Aug. 29, 2000
6107316	Method for treating protozoal infections	Aug. 22, 2000
6096736	Benzazepine derivatives with vasopressin agonistic activity	Aug. 1, 2000
6096735	Benzoheterocyclic derivatives	Aug. 1, 2000